Literature DB >> 25755491

Elevated alpha fetoprotein, no hepatocellular carcinoma.

Mallikarjun Patil1, Keyur A Sheth2, Channagiri K Adarsh2.   

Abstract

Alpha fetoprotein is a fetal specific glycoprotein which falls rapidly after birth. High level of alpha fetoprotein is suspicious of hepatocellular carcinoma but may be elevated in chronic viral hepatitis. A 35-year-old presented to us with jaundice for 7 days. He had chronic hepatitis B infection for last 12 months and was taking medicines irregularly for same. He had high alpha fetoprotein levels (740.9 ng/ml) without evidence of hepatocellular carcinoma which reduced with antiviral therapy. Such elevation can be explained due to hepatic inflammation and viral replication.

Entities:  

Keywords:  AFP, alpha fetoprotein; ALP, alkaline phosphatase; ALT, alanine aminotransferase; ANA, antinuclear antibody; ASMA, anti-smooth muscle antibody; AST, aspartate aminotransferase; GGT, gamma glutamyl transferase; HBeAg, hepatitis B virus e antigen; HCC, hepatocellular carcinoma; LCA, lens culinaris agglutinin; alpha fetoprotein (AFP); anti-LKM-1, anti-liver kidney microsomal antibody; hepatitis B infection; hepatocellular carcinoma (HCC)

Year:  2013        PMID: 25755491      PMCID: PMC3940329          DOI: 10.1016/j.jceh.2013.02.246

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  8 in total

1.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

2.  The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.

Authors:  Angelo Sangiovanni; Gian Maria Prati; Pierangelo Fasani; Guido Ronchi; Raffaella Romeo; Matteo Manini; Ersilio Del Ninno; Alberto Morabito; Massimo Colombo
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

3.  Dramatic reduction of the alpha-fetoprotein level after lamivudine treatment of patients with chronic hepatitis B virus infection and cirrhosis.

Authors:  Francis Y Yao
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

Review 4.  Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.

Authors:  Bruno Daniele; Alfonso Bencivenga; Angelo Salomone Megna; Vincenza Tinessa
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 5.  Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Authors:  Samir Gupta; Stephen Bent; Jeffrey Kohlwes
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

Review 6.  Serum tumor markers for detection of hepatocellular carcinoma.

Authors:  Lin Zhou; Jia Liu; Feng Luo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

7.  Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.

Authors:  Maurizio Soresi; Carmela Magliarisi; Pietro Campagna; Gaetano Leto; Giulio Bonfissuto; Anna Riili; Antonio Carroccio; Roberta Sesti; Silvio Tripi; Giuseppe Montalto
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

8.  Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.

Authors:  Jin Soo Bae; Sang Jong Park; Kwang Bo Park; So Ya Paik; Jin Kyung Ryu; Chang Kyu Choi; Tae Joon Hwang
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

  8 in total
  7 in total

1.  Superparamagnetic Iron Oxide-enhanced Magnetic Resonance Imaging of Spontaneous Hepatic Neoplasia in a Cynomolgus Macaque (Macaca fascicularis).

Authors:  Yasuyo Ito Fujishiro; Hiroshi Koie; Shunya Nakayama; Hiroaki Shibata; Sachi Okabayashi; Yuko Katakai; Kiichi Kanayama; Yasuhiro Yasutomi; Naohide Ageyama
Journal:  Comp Med       Date:  2018-05-29       Impact factor: 0.982

2.  Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.

Authors:  Rania Refaat; Mohammad Abd Alkhalik Basha; Mohammed Sobhi Hassan; Rasha S Hussein; Ahmed A El Sammak; Dena Abd El Aziz El Sammak; Mohamed Hesham Saleh Radwan; Nahla M Awad; Somaia A Saad El-Din; Engi Elkholy; Dina R D Ibrahim; Shereen A Saleh; Iman F Montasser; Hany Said
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

3.  Protective and therapeutic effects of sildenafil and tadalafil on aflatoxin B1-induced hepatocellular carcinoma.

Authors:  Saurabh K Chhonker; Divya Rawat; Raj Kumar Koiri
Journal:  Mol Cell Biochem       Date:  2020-11-20       Impact factor: 3.396

4.  Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case report.

Authors:  Young-Min Yoon; Da-Yeong Kang; Da-Young Kim; Jun-Won Seo; Hyun-Jong Lim; Hee-Jeong Lee; Sang-Gon Park
Journal:  J Med Case Rep       Date:  2016-06-01

5.  Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.

Authors:  Jiahao Chen; Manli Wu; Jiao Gong; Zhihuan Liu; Guowei He; Huiqing Zhu; Zhaoxia Li; Bo Hu
Journal:  Biomed Res Int       Date:  2020-12-15       Impact factor: 3.411

6.  Comparative Protective Effects of N-Acetylcysteine, N-Acetyl Methionine, and N-Acetyl Glucosamine against Paracetamol and Phenacetin Therapeutic Doses-Induced Hepatotoxicity in Rats.

Authors:  Tahia H Saleem; Nagwa Abo El-Maali; Mohammed H Hassan; Nahed A Mohamed; Nashwa A M Mostafa; Emaad Abdel-Kahaar; Azza S Tammam
Journal:  Int J Hepatol       Date:  2018-09-02

Review 7.  Screening for Hepatocellular Carcinoma in Patients with Hepatitis B.

Authors:  Yashasavi Sachar; Mayur Brahmania; Renumathy Dhanasekaran; Stephen E Congly
Journal:  Viruses       Date:  2021-07-08       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.